DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
de Bono JS, Oudard S, Ozguroglu M, Hansen S, Machiels JP, Kocak I. et al.
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: A randomised open-label trial.
Lancet 2010;
376: 1147-54
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.